Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine Mesilate for Vertigo in Posterior Circulation Infarction
NCT00474409Phase 4Withdrawn
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of betahistine in vertigo, sponsored by Eisai Co., Ltd.. Planned start May 2007; status: withdrawn.
02
Drugs
betahistine
03
Conditions
vertigo
Beyond the preview
Go deeper on NCT00474409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474409.